mercaptoethanol and ifosfamide

mercaptoethanol has been researched along with ifosfamide in 79 studies

Research

Studies (79)

TimeframeStudies, this research(%)All Research%
pre-199067 (84.81)18.7374
1990's12 (15.19)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brock, N; Pohl, J; Stekar, J2
Burkert, H; Fichtner, E; Schnitker, J1
Marti, C; Steiner, R; Viollier, AF1
Antman, KH; Begg, CB; Eder, JP; Elias, AD; Frei, E; Shea, T1
Goren, MP; Pratt, CB2
Fujiwara, F; Imashuku, S; Iwasaku-Fujimoto, M; Morioka, Y; Todo, S1
Dana, WJ; Schoenike, SE1
Araujo, CE; Brosto, M; Cervellino, JC; Pirisi, C; Rossi, R; Sanchez, O1
Aalders, JG; de Vries, EG; Neijt, JP; ten Bokkel Huinink, WW; vd Burg, ME; vd Gaast, A; Willemse, PH1
Berman, ML; Blessing, JA; Homesley, HD; Photopulos, G; Sutton, GP2
Beauduin, M; Closon, MT; Focan, C; Majois, F; Michel, J; Paridaens, R; Piccart, M; Salamon, E; Tueni, E; Vindevoghel, A1
Milla, A; Sanchiz, F1
Dorr, RT1
Einhorn, LH; Loehrer, PJ; Munshi, N; Williams, SD1
Dhingra, HM; Glisson, BS; Holoye, PY; Hong, WK; Jeffries, D; Lee, JS; Levy, JK; Murphy, WK; Raber, MN; Umsawasdi, T1
Antman, KH; Elias, A; Grier, HE; Ryan, L; Sherman, D1
Boossy, J; Claessens, JJ; Focan, C; Focan-Henrard, D; Reginster, M1
Douglass, EC; Etcubanas, E; Goren, MP; Green, AA; Hayes, FA; Horowitz, ME; Meyer, WH; Pratt, CB; Thompson, EI; Wilimas, JA1
de Jong, PE; Elema, JD; Mulder, NH; Willemse, PH1
de Vries, EG; Willemse, PH1
Exner, U; Göbel, U; Jürgens, H; Kühl, J; Ritter, J; Treuner, J; Weinel, P; Winkler, K1
Falkson, CI; Falkson, G; Falkson, HC1
Berman, ML; Blessing, JA; Homesley, HD; Malfetano, J; Sutton, GP1
Dodge, RK; Goren, MP; Meyer, WH; Pratt, CB; Viar, MJ; Wright, RK1
Castel, V; Esquembre, C; Fernandez, JM; Ferris, J; Ruiz, JG; Verdeguer, A1
Blackledge, G; Blake, AE; Blake, DR; Honigsberger, L; Latief, TN; Meanwell, CA; Mould, JJ; Shaw, IC; Spooner, D; Williams, AC1
Cantwell, BM; Harris, AL1
Blackledge, G; Kelly, KA; Meanwell, CA1
Harrop, JS; Hill, PG1
Blackledge, G; Constantine, G; Meanwell, C1
Goren, MP; Horowitz, ME; Pratt, CB; Wright, RK1
Perren, TJ; Smith, IE; Turner, RC1
McCallum, AK1
Husband, DJ; Watkin, SW1
Brock, N; Dietrich, I; Hilgard, P; Manz, I; Niemeyer, U; Pohl, J; Przybylski, M1
Beuzeboc, P; Dorval, T; Garcia-Giralt, E; Jouve, M; Livartowski, A; Palangie, T; Pouillart, P; Scholl, S1
Bozzino, JM; Cantwell, BM; Harris, AL1
Cantwell, BM; Harris, AL; Pooley, J1
Eguchi, K; Jett, JR; Saijo, N; Sakurai, M; Sano, T; Sasaki, Y; Shinkai, T; Suemasu, K; Tamura, T1
Blackledge, G; Blake, AE; Honigsberger, L; Kelly, KA; Meanwell, CA1
Christian, E; Coerper, C; Dias Wickramanayake, P; Klein, HO1
Andriole, GL; Arasi, V; Linehan, M; Magrath, IT; Miser, JS; Sandlund, JT1
Brock, N; Pohl, J1
Akatchereian, C; Flamant, F; Ghosn, M; Salloum, E; Taleb, N1
De Forges, A; Droz, JP; Ghosn, M; Theodore, C1
Cantwell, BM; Carmichael, J; Ghani, S; Harris, AL1
Alberts, AS; Falkson, G; Van Zyl, L1
Anderson, J; Case, DC; Ervin, TJ; Gottlieb, A1
Carde, P; Droz, JP; Flamant, F; Friedman, S; Ghosn, M; Hayat, M; Leclerq, B1
Brock, N; Guan, ZZ; He, YJ; Li, GC; Li, JQ1
Abbruzzese, JL; Ajani, JA; Boman, BM; Faintuch, JS; Goudeau, P; Levin, B; Nicaise, C; Yeomans, AC1
Brade, WP; Dittrich, C; Herold, C; Keller, A; Mader, R; Moser, K; Schlappack, O; Steger, GG1
Bryant, BM; Ford, HT; Jarman, M; Smith, IE1
Rose, JW; Shaw, IC1
Adams, P; Bradford, E; Haines-Nutt, RP; Jakobson, K; Rowland, CG1
Araujo, CE; Tessler, J1
Göbel, D; Matthiessen, W; Stempinski, E; Thalmann, U1
Harper, PG; Kaye, SB; Stuart-Harris, R; Wiltshaw, E1
de Kraker, J; Voûte, PA1
Brock, N; Christian, E; Coerper, C; Klein, HO; Pohl, J; Wickramanayake, PD1
Burkert, H1
Christian, E; Coerper, C; Graf, L; Klein, HO; Wickramanayake, PD1
Bremer, K; Niederle, N; Scheulen, ME; Schütte, J; Seeber, S1
Gowing, NF; Harper, PG; Kaye, SB; Mooney, CA; Parsons, CA; Stuart-Harris, RC; Wiltshaw, E1
Calman, KC; Dalton, JF; Kaye, SB; Sangster, G1
Burkert, H; Hilgard, P1
Breuel, HP; Burkert, H; Lücker, PW; Wetzelsberger, N1
Brock, N1
Czownicki, Z; Utracka-Hutka, B1
Brock, N; Stekar, J1
Falkson, G; Falkson, HC; Stapelberg, R; Van Dyk, JJ1
Brock, N; Pohl, J; Scheef, W; Stekar, J1

Reviews

2 review(s) available for mercaptoethanol and ifosfamide

ArticleYear
Ifosfamide and mesna.
    Clinical pharmacy, 1990, Volume: 9, Issue:3

    Topics: Animals; Humans; Ifosfamide; Mercaptoethanol; Mesna; Neoplasms

1990
Mitomycin, ifosfamide, and mesna in the treatment of lung cancer.
    Seminars in oncology, 1990, Volume: 17, Issue:4 Suppl 7

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance; Humans; Ifosfamide; Lung Neoplasms; Mercaptoethanol; Mesna; Mitomycins

1990

Trials

9 trial(s) available for mercaptoethanol and ifosfamide

ArticleYear
Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:1

    Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Clinical Trials as Topic; Female; Hematuria; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Middle Aged; Sarcoma; Soft Tissue Neoplasms

1989
Phase II trial of ifosfamide and mesna in advanced ovarian carcinoma: a Gynecologic Oncology Group Study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:11

    Topics: Carcinoma; Drug Evaluation; Female; Humans; Ifosfamide; Leukocyte Count; Mercaptoethanol; Mesna; Multicenter Studies as Topic; Ovarian Neoplasms; Platelet Count

1989
Experience with 24-h infusions of ifosfamide/mesna in small cell lung cancer.
    Cancer chemotherapy and pharmacology, 1986, Volume: 18 Suppl 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Drug Evaluation; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Mercaptoethanol; Mesna

1986
The protective effect of 2-mercapto-ethane sulfonate (MESNA) on hemorrhagic cystitis induced by high-dose ifosfamide treatment tested by a randomized crossover trial.
    Japanese journal of clinical oncology, 1986, Volume: 16, Issue:2

    Topics: Adult; Aged; Clinical Trials as Topic; Cystitis; Female; Hemorrhage; Humans; Ifosfamide; Lung Neoplasms; Male; Mercaptoethanol; Mesna; Middle Aged; Random Allocation

1986
Ifosfamide and mesna: marginally active in patients with advanced carcinoma of the pancreas.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1988, Volume: 6, Issue:11

    Topics: Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Middle Aged; Pancreatic Neoplasms

1988
Prevention of isophosphamide-induced urothelial toxicity with 2-mercaptoethane sulphonate sodium (mesnum) in patients with advanced carcinoma.
    Lancet (London, England), 1980, Sep-27, Volume: 2, Issue:8196

    Topics: Acrolein; Carcinoma, Bronchogenic; Clinical Trials as Topic; Cyclophosphamide; Female; Hematuria; Humans; Ifosfamide; Kinetics; Lung Neoplasms; Male; Mercaptoethanol; Mesna; Phosphoramide Mustards; Urinary Bladder

1980
Treatment of ifosfamide-induced urothelial toxicity by oral administration of sodium 2-mercaptoethane sulphonate (MESNA) to patients with inoperable lung cancer.
    European journal of cancer & clinical oncology, 1983, Volume: 19, Issue:2

    Topics: Administration, Oral; Adult; Aged; Carcinoma, Squamous Cell; Cyclophosphamide; Drug Therapy, Combination; Humans; Ifosfamide; Lung Neoplasms; Male; Mercaptoethanol; Mesna; Middle Aged; Urinary Bladder Diseases

1983
Clinical overview of mesna.
    Cancer treatment reviews, 1983, Volume: 10 Suppl A

    Topics: Clinical Trials as Topic; Cyclophosphamide; Drug Interactions; Hematuria; Humans; Ifosfamide; Mercaptoethanol; Mesna; Neoplasms

1983
[Clinical evaluation of Mitexan in the prevention of urinary tract complications during treatment with Holoxan].
    Nowotwory, 1981, Volume: 30, Issue:4

    Topics: Clinical Trials as Topic; Cyclophosphamide; Cystitis; Hematuria; Humans; Ifosfamide; Mercaptoethanol; Mesna; Neoplasms

1981

Other Studies

68 other study(ies) available for mercaptoethanol and ifosfamide

ArticleYear
[Antidote against the urotoxic effects of the oxazaphorine derivatives cyclophosphamide, ifosfamide and trofosfamide].
    Die Naturwissenschaften, 1979, Volume: 66, Issue:1

    Topics: Animals; Antidotes; Carcinosarcoma; Cyclophosphamide; Ifosfamide; Mercaptoethanol; Mesna; Phosphoramide Mustards; Rats; Urine

1979
[Prevention of urinary tract toxicity of oxazaphosphorines by a "uroprotector". Report on a field study (author's transl)].
    MMW, Munchener medizinische Wochenschrift, 1979, Jun-01, Volume: 121, Issue:22

    Topics: Adolescent; Adult; Aged; Bronchial Neoplasms; Child; Cyclophosphamide; Female; Gastrointestinal Diseases; Hematuria; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Middle Aged; Ovarian Neoplasms; Phosphoramide Mustards; Testicular Neoplasms

1979
[High-dose ifosfamide therapy: systemic use of a mucolytic agent for the reduction of urotoxicity].
    Schweizerische medizinische Wochenschrift, 1979, Dec-08, Volume: 109, Issue:47

    Topics: Adult; Cyclophosphamide; Cystitis; Hematuria; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Osteosarcoma

1979
High-dose ifosfamide with mesna uroprotection: a phase I study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:1

    Topics: Blood; Bone Marrow; Central Nervous System; Dose-Response Relationship, Drug; Drug Evaluation; Drug Interactions; Drug Therapy, Combination; Humans; Ifosfamide; Kidney; Mercaptoethanol; Mesna; Neoplasms; Remission Induction; Time Factors; Urinary Tract

1990
False-positive ketone tests: a bedside measure of urinary mesna.
    Cancer chemotherapy and pharmacology, 1990, Volume: 25, Issue:5

    Topics: Adolescent; Child; False Positive Reactions; Female; Humans; Ifosfamide; Ketones; Mercaptoethanol; Mesna

1990
[Effects of mesna (2-mercaptoethane sodium sulfonate) in children with malignant disease receiving oxazaphosphorine chemotherapy].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1990, Volume: 17, Issue:3 Pt 1

    Topics: Bone Neoplasms; Child; Cyclophosphamide; Cystitis; Female; Hematuria; Humans; Ifosfamide; Leukemia; Lymphoma, Non-Hodgkin; Male; Mercaptoethanol; Mesna; Neuroblastoma; Osteosarcoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rhabdomyosarcoma

1990
Ifosfamide and mesna at high doses for the treatment of cancer of the cervix: a GETLAC study.
    Cancer chemotherapy and pharmacology, 1990, Volume: 26 Suppl

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna; Middle Aged; Uterine Cervical Neoplasms

1990
Ifosfamide given as a 24-h infusion with mesna in patients with recurrent ovarian cancer: preliminary results.
    Cancer chemotherapy and pharmacology, 1990, Volume: 26 Suppl

    Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Ifosfamide; Infusions, Intravenous; Mercaptoethanol; Mesna; Neoplasm Recurrence, Local; Ovarian Neoplasms

1990
Early phase II Gynecologic Oncology Group experience with ifosfamide/mesna in gynecologic malignancies.
    Cancer chemotherapy and pharmacology, 1990, Volume: 26 Suppl

    Topics: Antineoplastic Agents; Carcinoma; Drug Evaluation; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna; Middle Aged; Ovarian Neoplasms; Sarcoma; Uterine Cervical Neoplasms

1990
Experience of the Belgian Society of Medical Oncology with single-administration 5 g/m2 ifosfamide with mesna as second- or third-line therapy in advanced breast cancer.
    Cancer chemotherapy and pharmacology, 1990, Volume: 26 Suppl

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna; Middle Aged

1990
High-dose ifosfamide and mesna in advanced breast cancer. A phase II study.
    Cancer chemotherapy and pharmacology, 1990, Volume: 26 Suppl

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Evaluation; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna; Middle Aged

1990
Cyclophosphamide and ifosfamide: role of uroprotective agents.
    Cancer investigation, 1990, Volume: 8, Issue:2

    Topics: Acetylcysteine; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Hematuria; Humans; Ifosfamide; Mercaptoethanol; Mesna; Urogenital Neoplasms

1990
Ifosfamide with mesna uroprotection in the management of lung cancer.
    American journal of clinical oncology, 1990, Volume: 13, Issue:2

    Topics: Aged; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mercaptoethanol; Mesna; Middle Aged; Survival Rate; Urologic Diseases; Vincristine

1990
Phase II trial with high-dose ifosfamide and mesna given in a 24-h infusion for advanced GI tract cancer.
    Cancer chemotherapy and pharmacology, 1989, Volume: 23, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Gastrointestinal Neoplasms; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Middle Aged

1989
Clinical studies of ifosfamide/mesna at St Jude Children's Research Hospital, 1983-1988.
    Seminars in oncology, 1989, Volume: 16, Issue:1 Suppl 3

    Topics: Adolescent; Child; Child, Preschool; Drug Evaluation; Humans; Ifosfamide; Infant; Mercaptoethanol; Mesna; Neoplasms; Remission Induction; Sarcoma

1989
Severe renal failure following high-dose ifosfamide and mesna.
    Cancer chemotherapy and pharmacology, 1989, Volume: 23, Issue:5

    Topics: Acute Kidney Injury; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma; Dose-Response Relationship, Drug; Female; Humans; Ifosfamide; Kidney; Mercaptoethanol; Mesna; Middle Aged; Ovarian Neoplasms

1989
Mesna: continuous or bolus infusion?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:6

    Topics: Drug Administration Schedule; Humans; Ifosfamide; Infusions, Intravenous; Injections, Intravenous; Mercaptoethanol; Mesna; Sarcoma; Soft Tissue Neoplasms

1989
High-dose ifosfamide with mesna uroprotection in Ewing's sarcoma.
    Cancer chemotherapy and pharmacology, 1989, Volume: 24 Suppl 1

    Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Neoplasm Recurrence, Local; Sarcoma, Ewing; Vincristine

1989
Ifosfamide and mesna in the treatment of malignant disease mesna as urothelial protector.
    Investigational new drugs, 1989, Volume: 7, Issue:2-3

    Topics: Adult; Aged; Drug Therapy, Combination; Female; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Middle Aged; Neoplasms; Urologic Diseases

1989
Mesna excretion and ifosfamide nephrotoxicity in children.
    Cancer research, 1989, Dec-15, Volume: 49, Issue:24 Pt 1

    Topics: Adolescent; Adult; Child; Child, Preschool; Creatinine; Female; Humans; Ifosfamide; Kidney Diseases; Male; Mercaptoethanol; Mesna; Neoplasms; Proteinuria

1989
Fatal encephalopathy with ifosfamide/mesna.
    Pediatric hematology and oncology, 1989, Volume: 6, Issue:4

    Topics: Brain Diseases; Child; Drug Therapy, Combination; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Rhabdomyosarcoma

1989
Phase II experience with ifosfamide/mesna in gynecologic malignancies: preliminary report of Gynecologic Oncology Group studies.
    Seminars in oncology, 1989, Volume: 16, Issue:1 Suppl 3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Drug Evaluation; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna; Middle Aged; Neoplasms, Germ Cell and Embryonal; Organoplatinum Compounds; Ovarian Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms

1989
Ifosfamide and mesna.
    The Medical letter on drugs and therapeutics, 1989, Nov-03, Volume: 31, Issue:804

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cystitis; Hemorrhage; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Neoplasms, Germ Cell and Embryonal; Testicular Neoplasms

1989
Encephalopathy associated with ifosphamide/mesna therapy.
    Lancet (London, England), 1985, Feb-16, Volume: 1, Issue:8425

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Cyclophosphamide; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna; Uterine Neoplasms

1985
Ifosfamide/mesa and encephalopathy.
    Lancet (London, England), 1985, Mar-30, Volume: 1, Issue:8431

    Topics: Brain Diseases; Carcinoma, Small Cell; Cyclophosphamide; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mercaptoethanol; Mesna; Middle Aged; Sarcoma

1985
Ifosfamide, mesna, and encephalopathy.
    Lancet (London, England), 1985, Jun-15, Volume: 1, Issue:8442

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Child; Cyclophosphamide; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna

1985
Avoiding ifosfamide/mesna encephalopathy.
    Lancet (London, England), 1986, Aug-16, Volume: 2, Issue:8503

    Topics: Adolescent; Adult; Aged; Brain Diseases; Drug Therapy, Combination; Female; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Middle Aged; Probability

1986
Ifosfamide/mesna nomogram and serum albumin.
    Lancet (London, England), 1986, Oct-25, Volume: 2, Issue:8513

    Topics: Drug Therapy, Combination; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna; Pelvic Inflammatory Disease; Serum Albumin

1986
Ifosfamide/mesna nomogram and serum albumin.
    Lancet (London, England), 1986, Nov-08, Volume: 2, Issue:8515

    Topics: Humans; Ifosfamide; Mercaptoethanol; Mesna; Methods; Serum Albumin

1986
Ifosfamide-induced subclinical tubular nephrotoxicity despite mesna.
    Cancer treatment reports, 1987, Volume: 71, Issue:2

    Topics: Acetylglucosaminidase; Adolescent; Adult; Aminopeptidases; CD13 Antigens; Child; Child, Preschool; Creatinine; Drug Evaluation; Female; Humans; Ifosfamide; Kidney Diseases; Kidney Tubules; Male; Mercaptoethanol; Mesna; Proteinuria

1987
Encephalopathy with rapid infusion ifosfamide/mesna.
    Lancet (London, England), 1987, Feb-14, Volume: 1, Issue:8529

    Topics: Brain Diseases; Drug Therapy, Combination; Humans; Ifosfamide; Infusions, Intravenous; Mercaptoethanol; Mesna

1987
Ifosfamide/mesna encephalopathy.
    Lancet (London, England), 1987, Apr-25, Volume: 1, Issue:8539

    Topics: Antineoplastic Combined Chemotherapy Protocols; Epilepsy, Tonic-Clonic; Female; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Middle Aged; Psychoses, Substance-Induced

1987
Fatal hypokalaemia associated with ifosfamide/mesna chemotherapy.
    Lancet (London, England), 1988, May-14, Volume: 1, Issue:8594

    Topics: Drug Therapy, Combination; Humans; Hypokalemia; Ifosfamide; Male; Mercaptoethanol; Mesna

1988
Identification and quantification of metabolite conjugates of activated cyclophosphamide and ifosfamide with mesna in urine by ion-pair extraction and fast atom bombardment mass spectrometry.
    Biomedical mass spectrometry, 1985, Volume: 12, Issue:9

    Topics: Acrolein; Animals; Cyclophosphamide; Ifosfamide; Kinetics; Mass Spectrometry; Mercaptoethanol; Mesna; Rats; Rats, Inbred Strains

1985
[Encephalopathy caused by an ifosfamide-mesna combination].
    Presse medicale (Paris, France : 1983), 1988, Apr-02, Volume: 17, Issue:12

    Topics: Adult; Brain Diseases; Drug Therapy, Combination; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna; Middle Aged

1988
False-positive ketonuria during ifosfamide and mesna therapy.
    European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:2

    Topics: False Positive Reactions; Female; Humans; Ifosfamide; Ketone Bodies; Lung Neoplasms; Male; Mercaptoethanol; Mesna; Middle Aged

1986
Prediction of ifosfamide/mesna associated encephalopathy.
    European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Electroencephalography; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mercaptoethanol; Mesna; Soft Tissue Neoplasms; Uterine Cervical Neoplasms; Uterine Neoplasms

1986
Recent experience with ifosfamide/mesna in solid tumors. International satellite symposium to the 3rd European Conference on Clinical Oncology. Stockholm, June 1985. Proceedings.
    Cancer chemotherapy and pharmacology, 1986, Volume: 18 Suppl 2

    Topics: Humans; Ifosfamide; Mercaptoethanol; Mesna; Neoplasms

1986
Treatment of advanced soft tissue and osteogenic sarcomas with continuous infusion of ifosfamide and mesna.
    Cancer chemotherapy and pharmacology, 1986, Volume: 18 Suppl 2

    Topics: Female; Humans; Ifosfamide; Infusions, Intravenous; Male; Mercaptoethanol; Mesna; Middle Aged; Osteosarcoma; Soft Tissue Neoplasms

1986
The efficacy of mesna (2-mercaptoethane sodium sulfonate) as a uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorine chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:5

    Topics: Adolescent; Adult; Child; Child, Preschool; Cyclophosphamide; Cystitis; Female; Hematuria; Hemorrhage; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Neoplasms

1987
Prevention of urotoxic side effects by regional detoxification with increased selectivity of oxazaphosphorine cytostatics.
    IARC scientific publications, 1986, Issue:78

    Topics: Animals; Biotransformation; Cyclophosphamide; DNA; Glutathione; Ifosfamide; Kidney; Leukemia, Experimental; Mercaptoethanol; Mesna; Rats; Structure-Activity Relationship; Urinary Bladder; Urinary Bladder Neoplasms

1986
Irreversible encephalopathy with ifosfamide/mesna.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Child, Preschool; Dactinomycin; Female; Humans; Ifosfamide; Maxillary Neoplasms; Mercaptoethanol; Mesna; Rhabdomyosarcoma; Vincristine

1987
Phase II trial of ifosfamide/mesna in metastatic adult renal carcinoma.
    Cancer treatment reports, 1987, Volume: 71, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Diagnosis-Related Groups; Drug Evaluation; Female; Humans; Ifosfamide; Kidney Neoplasms; Male; Mercaptoethanol; Mesna; Middle Aged

1987
Ifosfamide/mesna and hematuria.
    Cancer treatment reports, 1987, Volume: 71, Issue:11

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Hematuria; Humans; Ifosfamide; Infant; Mercaptoethanol; Mesna

1987
A phase II study of ifosfamide/mesna with doxorubicin for adult soft tissue sarcoma.
    Cancer chemotherapy and pharmacology, 1988, Volume: 21, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Doxorubicin; Drug Evaluation; Female; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Middle Aged; Sarcoma; Soft Tissue Neoplasms

1988
Malignant pleural mesothelioma: phase II pilot study of ifosfamide and mesna.
    Journal of the National Cancer Institute, 1988, Jul-06, Volume: 80, Issue:9

    Topics: Adolescent; Adult; Aged; Drug Evaluation; Female; Humans; Ifosfamide; Kidney Diseases; Male; Mercaptoethanol; Mesna; Mesothelioma; Middle Aged; Pleural Neoplasms

1988
Phase II trial of ifosfamide and mesna in previously treated patients with non-Hodgkin's lymphoma: Cancer and Leukemia Group B Study 8552.
    Medical and pediatric oncology, 1988, Volume: 16, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Drug Evaluation; Hematologic Diseases; Hematuria; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Mercaptoethanol; Mesna; Middle Aged

1988
Ifosfamide/mesna related encephalopathy: a case report with a possible role of phenobarbital in enhancing neurotoxicity.
    Bulletin du cancer, 1988, Volume: 75, Issue:4

    Topics: Adolescent; Brain Diseases; Drug Interactions; Drug Therapy, Combination; Epilepsy; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna; Phenobarbital

1988
Ifosfamide and Mesna in advanced malignancies.
    Chinese medical journal, 1988, Volume: 101, Issue:3

    Topics: Adult; Aged; Carcinoma, Bronchogenic; Female; Hematuria; Humans; Ifosfamide; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Mercaptoethanol; Mesna; Middle Aged; Neoplasms; Ovarian Neoplasms; Testicular Neoplasms

1988
Toxicity and response to high-dose ifosfamide + mesna as salvage therapy for advanced breast cancer.
    Journal of cancer research and clinical oncology, 1988, Volume: 114, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Ifosfamide; Mercaptoethanol; Mesna; Middle Aged

1988
Infusion of ifosphamide plus mesna.
    Lancet (London, England), 1984, Jun-16, Volume: 1, Issue:8390

    Topics: Cyclophosphamide; Drug Interactions; Humans; Ifosfamide; Infusions, Parenteral; Mercaptoethanol; Mesna; Urinary Bladder Neoplasms

1984
Infusion of ifosfamide plus mesna.
    Lancet (London, England), 1984, Aug-25, Volume: 2, Issue:8400

    Topics: Cyclophosphamide; Drug Combinations; Drug Stability; Drug Storage; Humans; Ifosfamide; Infusions, Parenteral; Mercaptoethanol; Mesna

1984
Proceedings of a symposium on ifosfamide (Mitoxana; Holoxan) and Mesna (Uromitexan). Coventry, U.K., 16-18 March 1983.
    Cancer treatment reviews, 1983, Volume: 10 Suppl A

    Topics: Animals; Cyclophosphamide; Humans; Ifosfamide; Mercaptoethanol; Mesna; Neoplasms

1983
Combination chemotherapy with adriamycin, ifosfamide and mesna in extensive-stage non-small cell bronchogenic carcinoma.
    Cancer treatment reviews, 1983, Volume: 10 Suppl A

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Cyclophosphamide; Doxorubicin; Humans; Ifosfamide; Lung Neoplasms; Mercaptoethanol; Mesna

1983
High-dose ifosfamide by infusion with mesna in advanced soft tissue sarcoma.
    Cancer treatment reviews, 1983, Volume: 10 Suppl A

    Topics: Adolescent; Adult; Aged; Cyclophosphamide; Female; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Middle Aged; Sarcoma; Soft Tissue Neoplasms

1983
Ifosfamide, mesna and vincristine in paediatric oncology.
    Cancer treatment reviews, 1983, Volume: 10 Suppl A

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Humans; Ifosfamide; Infant; Mercaptoethanol; Mesna; Neoplasms; Vincristine

1983
High-dose ifosfamide and mesna as continuous infusion over five days--a phase I/II trial.
    Cancer treatment reviews, 1983, Volume: 10 Suppl A

    Topics: Cyclophosphamide; Drug Evaluation; Humans; Ifosfamide; Mercaptoethanol; Mesna; Neoplasms

1983
Therapeutic effects of single-push or fractionated injections of cyclophosphamide or ifosfamide combined with mesna.
    Cancer treatment reviews, 1983, Volume: 10 Suppl A

    Topics: Animals; Cyclophosphamide; Drug Therapy, Combination; Ifosfamide; Male; Mercaptoethanol; Mesna; Mice; Mice, Inbred Strains; Neoplasms, Experimental

1983
Efficacy of ifosfamide in refractory malignant diseases and uroprotection by mesna: results of a clinical phase II-study with 151 patients.
    Cancer treatment reviews, 1983, Volume: 10 Suppl A

    Topics: Cyclophosphamide; Drug Evaluation; Drug Interactions; Female; Humans; Ifosfamide; Male; Mercaptoethanol; Mesna; Neoplasms; Testicular Neoplasms; Urinary Tract

1983
High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma.
    Cancer chemotherapy and pharmacology, 1983, Volume: 11, Issue:2

    Topics: Adolescent; Adult; Aged; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Ifosfamide; Kidney; Male; Mercaptoethanol; Mesna; Middle Aged; Sarcoma; Soft Tissue Neoplasms

1983
Failure of 2-mercaptoethane sulphonate sodium (mesna) to protect against ifosfamide nephrotoxicity.
    European journal of cancer & clinical oncology, 1984, Volume: 20, Issue:3

    Topics: Adult; Cyclophosphamide; Fanconi Syndrome; Female; Humans; Ifosfamide; Intestinal Neoplasms; Leiomyosarcoma; Mercaptoethanol; Mesna

1984
Sodium-2-mercaptoethanesulfonate (MESNA) and ifosfamide nephrotoxicity.
    European journal of cancer & clinical oncology, 1984, Volume: 20, Issue:11

    Topics: Cyclophosphamide; Humans; Ifosfamide; Infusions, Parenteral; Kidney Diseases; Mercaptoethanol; Mesna

1984
Bioavailability of orally administered mesna.
    Arzneimittel-Forschung, 1984, Volume: 34, Issue:11

    Topics: Administration, Oral; Adult; Antineoplastic Agents; Biological Availability; Cyclophosphamide; Humans; Ifosfamide; Injections, Intravenous; Male; Mercaptoethanol; Mesna

1984
The development of mesna for the inhibition of urotoxic side effects of cyclophosphamide, ifosfamide, and other oxazaphosphorine cytostatics.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1980, Volume: 74

    Topics: Animals; Antineoplastic Agents; Cyclophosphamide; Cystitis; Erythrocyte Count; Ifosfamide; Mercaptoethanol; Mesna; Rats; Urologic Diseases

1980
Detoxification of urotoxic oxazaphosphorines by sulfhydryl compounds.
    Journal of cancer research and clinical oncology, 1981, Volume: 100, Issue:3

    Topics: Animals; Cyclophosphamide; Cystitis; Female; Ifosfamide; Kidney; Mercaptoethanol; Mesna; Rats; Urinary Bladder

1981
[Prevention of urotoxic actions of cyclophosphamide and ifosfamide by dimesna (preliminary communication) (author's transl)].
    Arzneimittel-Forschung, 1982, Volume: 32, Issue:5

    Topics: Animals; Cyclophosphamide; Ifosfamide; Kidney Diseases; Mercaptoethanol; Mesna; Oxidation-Reduction; Rats; Rats, Inbred Strains

1982
Mesnum as a protector against kidney and bladder toxicity with high-dose ifosfamide treatment.
    Cancer chemotherapy and pharmacology, 1982, Volume: 9, Issue:2

    Topics: Adult; Aged; Cyclophosphamide; Female; Humans; Ifosfamide; Kidney Diseases; Leukopenia; Male; Mercaptoethanol; Mesna; Middle Aged; Neoplasms; Urinary Bladder Diseases

1982
Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna).
    European journal of cancer & clinical oncology, 1982, Volume: 18, Issue:12

    Topics: Animals; Cyclophosphamide; Dogs; Drug Interactions; Female; Ifosfamide; Kinetics; Lethal Dose 50; Male; Mercaptoethanol; Mesna; Mice; Neoplasms, Experimental; Proscillaridin; Rats; Urinary Bladder Diseases

1982